Studies implicating S100β as a candidate marker for dementia are often performed in cerebrospinal fluid5,7,8, which may provide a closer reflection of brain pathology and comparisons between blood and CSF S100β levels may therefore yield differing conclusions. The gene discussed is S100B; the disease is dementia.